BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6887553)

  • 1. [Trends in the development of immunomodulators based physiopathological mechanisms of various types of hypersensitivities].
    Abe T
    Nihon Rinsho; 1983; 41(4):852-6. PubMed ID: 6887553
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug therapy of vasculitis with immunosuppressive agents, immunomodulators and cyclosporin A].
    Abe C
    Nihon Rinsho; 1985 Oct; 43(10):2196-9. PubMed ID: 3912547
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development and clinical use of chemical immunomodulators].
    Abe T
    Nihon Rinsho; 1981 Apr; 39(4):1893-901. PubMed ID: 6796722
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current therapy: immunopharmaceuticals].
    Mahrle G
    Z Hautkr; 1987 May; 62(10):753-6, 759-62, 765. PubMed ID: 2887076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-inflammatory or antirheumatic agents? Pharmacological activity and therapeutic effectiveness of non-steroid anti-inflammatory drugs: comparative study. III].
    Mariani L; Baratelli M
    Clin Ter; 1980 Feb; 92(4):331-58. PubMed ID: 7004749
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possibilities and trends of immunopharmacology].
    Kovalev IE
    Patol Fiziol Eksp Ter; 1981; (3):65-71. PubMed ID: 7279454
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there a place for corticosteroids or immune modulation in treating Reiter's syndrome and ankylosing spondylitis?
    Rosenthal M
    Ann Rheum Dis; 1979; 38 Suppl 1(Suppl 1):suppl 100-1. PubMed ID: 263451
    [No Abstract]   [Full Text] [Related]  

  • 8. [Principle of immunoregulation in the treatment of chronic inflammatory rheumatism].
    Duţu A; Boloşiu HD
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(3):193-203. PubMed ID: 6084276
    [No Abstract]   [Full Text] [Related]  

  • 9. [New trends in immunotherapy of rheumatoid arthritis].
    Todesco S; Fiocco U; Cozzi L
    Clin Ter; 1991 Dec 15-31; 139(5-6):257-63. PubMed ID: 1802515
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatological news (2). The twilight of immunosuppression in hepatitis B--the dawn of new methods?].
    Juszczyk J
    Pol Tyg Lek; 1982 Nov; 37(43):1295-300. PubMed ID: 6761672
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of immunomodulators in the management of autoimmune diseases].
    Shiokawa Y
    Nihon Rinsho; 1981 Apr; 39(4):1909-13. PubMed ID: 7310992
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunomodulator therapy in chronic viral hepatitis].
    Stanciu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(6):491-502. PubMed ID: 2484221
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prediction of the effectiveness of levamisole immunotherapy by the sensitivity of blood lymphocytes to the drug].
    Giulling EV; Kravchuk GP; Kazirchuk VE; Maksiuk LV; Zabolotnyĭ DI
    Vrach Delo; 1984 Nov; (11):38-42. PubMed ID: 6335615
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of resistant pulmonary tuberculosis using chemotherapy and immunomodulators].
    Olmedo Zenteno C; López Aja J; Rojas García O; Salazar Riverol H; Yarce Palacios E
    Salud Publica Mex; 1983; 25(2):151-9. PubMed ID: 6879325
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy of autoimmune diseases.
    Bach JF
    Recenti Prog Med; 1988; 79(7-8):343-50. PubMed ID: 3059421
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunotherapy of carcinoma of the lung].
    Sega E; Mineo TC; Rea SR; Sega FM; Ricci C
    Recenti Prog Med; 1978 Mar; 64(3):293-309. PubMed ID: 351751
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current approaches to the problem of correcting hyper-IgE antibody production].
    Giulling EV; Diugovskaia LA
    Fiziol Zh (1978); 1982; 28(4):491-5. PubMed ID: 6981529
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on search for a promising immunopotentiative substance for treatment of leprosy. III. With special reference to an immunomodulative drug CCA, a BCG vaccine and the significance of an improved rabbit red blood cell rosette formation test.
    Gidoh M; Tsutsumi S
    Nihon Rai Gakkai Zasshi; 1983; 52(3):165-79. PubMed ID: 6678932
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunotherapy of cancer using levamisole, immunologic control of the post-surgical patient and graphic follow-up].
    de Carli HO; Llargues JM
    Rev Esp Oncol; 1980; 27(1):67-80. PubMed ID: 7209109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Principles of immunologic therapy. Elements for a new strategy].
    Bach JF
    Rev Prat; 1980 Mar; 30(15):895-8, 903-5. PubMed ID: 7375788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.